Nov 20 2022
Oral cannabinoid therapy seems to be safe and at least mildly effective in patients with treatment refractory chronic pain, according to a new European Journal of Pain study. “Cannabinoids are considered a therapeutic option to patients suffering from treatment refractory chronic pain (TRCP) insufficiently relieved by conventional analgesics or experiencing intolerable adverse events (AEs) from …
Nov 18 2022
Cannabidiol (CBD) enriched with terpenes may provide a safe and effective treatment option for autism spectrum disorder and is more effectice than CBD alone. This is according to a case report study being published in the journal Frontiers in Pharmacology and epublished by the U.S. National Library of Medicine. “Cannabidiol (CBD) rich products are successfully …
Nov 17 2022
Legalizing recreational marijuana at the state level doesn’t have a significant impact on crime rates, according to a new study published in the Journal of Drug Issues. For the study researchers affiliated with the University of Colorado and Boise State University compared crime data in Colorado and Washington – the first two states to legalize marijuana …
Nov 14 2022
According to a study epublished by the U.S. National Library of Medicine, “administration of the phytocannabinoid Δ9THC promotes significant recovery from TBI (traumatic brain injury).” Conducted by researchers at the University of South Florida and the James Haley VA Medical Center, the study was published in a recent issue of the peer-reviewed journal Cannabis and …
Nov 13 2022
A new study conducted by researchers at the Penn State College of Medicine has found that while CBD alone is not incredibly effective at treating neuropathic pain, it is effective when mixed with THC, and THC is effective when administered by itself. Published by the journal Biomedicines, the full text of the study can be found …
Nov 11 2022
Medical cannabis treatment was associated with increased white matter coherence in a new peer-reviewed study conducted by researchers at Harvard Medical School and published in the journal Cannabis and Cannabinoid Research. As noted by the study’s abstract, which was published online ahead of print by the National Institute of Health, previous studies have demonstrated abnormal …
Nov 10 2022
A new study provides evidence “supporting efficacy and tolerability of a full-spectrum, high-CBD product for anxiety.” Published in the journal Communications Medicine and conducted by researchers at Harvard Medical School, the study is titled Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial. The study …
Nov 07 2022
According to a study published in the peer-reviewed journal Cannabis and Cannabinoid Research and epublished ahead of print by the National Institute of Health, “medical cannabis may improve their quality of life and comorbidities” in those with Tourette’s syndrome. The study, titled Use of Medical Cannabis in Patients with Gilles de la Tourette’s Syndrome in …
Nov 07 2022
Cannabidiol (CBD) may alleviate liver and skin fibrosis according to a new study published by the peer-reviewed journal Frontiers in Pharmacology. “Cannabidiol (CBD) has been suggested as a potential therapy for inflammatory and fibrotic diseases”, states the study’s abstract. “Cannabidiol was demonstrated to reduce alcohol-induced liver inflammation and steatosis but its specific activity on the …
Nov 03 2022
According to a new study published in the Journal of Clinical Medicine, “cannabis use was associated with a lower risk of hypertension and a lower number of metabolic disorders” among those with the Hepatitis C virus. For the study researchers examined the relationship between current and/or lifetime cannabis use and metabolic disorders in a cohort …
